Vivozon Pharmaceutical비보존 제약
082800 · KOSDAQ · ₩082800 · 비보존 제약
₩2,915▼ ₩45 (1.52%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Adjustment of Conversion Price (21st Series)전환가액의조정 (제21회차)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: +6.1% vs sector, volume 1.4× normal (5 trading days)
Convertible bond conversion price adjustment; routine, dilution size not disclosed in the data.
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 6, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Sep 22, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 21, 2026Open on DART
- Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Aug 19, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Aug 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 7, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 7, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Jul 31, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jul 10, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Jul 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 30, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 19, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)May 26, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 7, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance (15th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제15회차)Apr 30, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 15, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Apr 15, 2026Open on DART
- Treasury share sale decision주요사항보고서(자기주식처분결정)Apr 10, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 9, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 6, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 3, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Apr 1, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) Before Maturity After Issuance (15th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제15회차)Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 31, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 23, 2026Open on DART
- Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 23, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 16, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 11, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 11, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 11, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure) (Rights Offering Followed by General Public Offering of Unsubscribed Shares)증권발행결과(자율공시) (주주배정 후 실권주 일반공모)Mar 4, 2026Open on DART
- Securities Issuance Results Report증권발행실적보고서Mar 4, 2026Open on DART
- Subscription Results for Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) (General Public Offering of Shares Not Subscribed in Shareholder Allotment)유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)Feb 25, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 20, 2026Open on DART
- Final Issue Price Confirmed for Rights Offering (Unsubscribed Shares from Shareholder Allotment to General Public Offering)유상증자최종발행가액확정 (주주배정후 실권주 일반공모)Feb 19, 2026Open on DART
- Amended: Prospectus[기재정정]투자설명서Feb 19, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Vivozon Pharmaceutical / 비보존 제약 / 082800 / KRX:082800
Source: KRX statistical information